WS #15960
UnitedHealth Group’s third-quarter earnings beat and raised full-year guidance triggered a surge in the Healthcare Select Sector SPDR Fund (XLV) to its first intraday record since mid-August. This move reflects a broader defensive rotation by institutional investors seeking stability and dividend support in the face of rising inflation and geopolitical volatility. Lilly, J&J, and Merck are leading the charge, benefiting from the flight-to-safety dynamic.
Healthcare Defensive Rotation
UnitedHealth Group’s third-quarter earnings beat and raised full-year guidance triggered a surge in the Healthcare Select Sector SPDR Fund (XLV) to its first intraday record since mid-August. This move reflects a broader defensive rotation by institutional investors seeking stability and dividend support in the face of rising inflation and geopolitical volatility. Lilly, J&J, and Merck are leading the charge, benefiting from the flight-to-safety dynamic.